BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Corteria Pharmaceuticals readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of studies Corteria Pharmaceuticals's drugs 
 run\, from ClinicalTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06815471-651@assetmemo.bio
DTSTAMP:20261121T005712Z
DTSTART;VALUE=DATE:20270731
DTEND;VALUE=DATE:20270801
SUMMARY:Corteria COR-1167: Phase 2 readout est. (NCT06815471)
DESCRIPTION:Corteria COR-1167\, phase 2\, Heart Failure.\nStudy: CRF2 Agoni
 st for the Treatment of Worsening Heart Failure\nEstimated primary complet
 ion: July 2027. This is a ClinicalTrials.gov estimate\, not a confirmed re
 adout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/corte
 ria-cor-1167#upcoming-events\nRegistry record: https://clinicaltrials.gov/
 study/NCT06815471
URL:https://assetmemo.bio/drug/corteria-cor-1167#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
